Tech Company Financing Transactions

BiO2 Medical Funding Round

Oxford Finance and private investors invested in a $14 million Series D funding round for BiO2 Medical. The financing round was announced on 1/7/2016.

Transaction Overview

Company Name
Announced On
1/7/2016
Transaction Type
Debt
Venture Equity
Amount
$14,000,000
Round
Series D
Proceeds Purpose
The financing included a $9m Series D funding round from unnamed backers and a $5m venture debt financing from Oxford Finance LLC (This transaction is structured to initially provide $5 million upon closing, with an option for an additional $3m to be provided upon FDA 510(k) clearance of the Angel Catheter). The company intends to use the funds for the US product launch, the expansion of the US and OUS sales force, incremental R&D projects, and general infrastructure development.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4670 Table Mountain Dr.
Golden, CO 80403
USA
Email Address
Overview
BiO2 Medical has created the Angel Catheter to protect critically ill patients from acute Pulmonary Embolism (PE). The innovative design incorporates a retrievable Inferior Vena Cava (IVC) filter, permanently attached to a triple lumen central venous catheter.
Profile
BiO2 Medical LinkedIn Company Profile
Social Media
BiO2 Medical Company Twitter Account
Company News
BiO2 Medical News
Facebook
BiO2 Medical on Facebook
YouTube
BiO2 Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christopher Banas
  Christopher Banas LinkedIn Profile  Christopher Banas Twitter Account  Christopher Banas News  Christopher Banas on Facebook
Chief Medical Officer
Luis Angel
  Luis Angel LinkedIn Profile  Luis Angel Twitter Account  Luis Angel News  Luis Angel on Facebook
Controller
Joseph Piercy
  Joseph Piercy LinkedIn Profile  Joseph Piercy Twitter Account  Joseph Piercy News  Joseph Piercy on Facebook
VP - Finance
Chad Frederickson
  Chad Frederickson LinkedIn Profile  Chad Frederickson Twitter Account  Chad Frederickson News  Chad Frederickson on Facebook
VP - R & D
Jeff Steinmetz
  Jeff Steinmetz LinkedIn Profile  Jeff Steinmetz Twitter Account  Jeff Steinmetz News  Jeff Steinmetz on Facebook
VP - Regulatory Affairs
Julie Ross
  Julie Ross LinkedIn Profile  Julie Ross Twitter Account  Julie Ross News  Julie Ross on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/7/2016: TAO Connect venture capital transaction
Next: 1/7/2016: Petra Pharma venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary